NHI
National Health InvestorsCAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
The Aug. 10 SEC earnings release provides concrete primary-source confirmation of the Q2 results, guidance, SHOP growth, NHC sale, and dividend increase. The Aug. 12 anchor price was $70.73, but the packet does not provide a clean post-release price comparison or trusted attribution of the market reaction. Social sentiment, options skew, short interest, employee sentiment, and reliable post-print analyst revisions are unavailable; confidence remains tentative.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
NHI's Aug. 10 SEC earnings release reported Q2 SHOP invested capital of $854.8 million, up 137% year over year, total SHOP NOI growth of approximately 188%, and completion of the NHC portfolio sale, which reduced leverage below target range. [#SEC-8K-2026-08-10]
The quarterly dividend increased to $0.94 from $0.92 per share. 2026 guidance assumes approximately $665 million of disposition proceeds and $180 million of unidentified new investments. [#SEC-8K-2026-08-10]
Normalized FFO per share declined 2.5% year over year to $1.19, same-store resident fees less operating expenses declined $0.2 million, and interest expense increased 5.4%; the market still needs evidence that acquisition-led SHOP growth converts into durable same-store performance. [#SEC-8K-2026-08-10]
Recommendation
No formal recommendation provided.

